Powder: -20°C for 3 years | In solvent: -80°C for 1 year
iKIX1 is an Pdr1-dependent gene activation. It re-sensitizes drug-resistant C. glabrata to azole antifungals in vitro and in animal models for disseminated and urinary tract C. glabrata infection.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 70.00 | |
10 mg | In stock | $ 133.00 | |
25 mg | In stock | $ 272.00 | |
50 mg | In stock | $ 397.00 | |
100 mg | In stock | $ 593.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 77.00 |
Description | iKIX1 is an Pdr1-dependent gene activation. It re-sensitizes drug-resistant C. glabrata to azole antifungals in vitro and in animal models for disseminated and urinary tract C. glabrata infection. |
Targets&IC50 | CgGal11A-CgPdr1:18 μM (Ki), CgGal11A-CgPdr1:190.2 μM (IC50) |
Molecular Weight | 303.17 |
Formula | C10H8Cl2N4OS |
CAS No. | 656222-54-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.03 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
iKIX1 656222-54-7 Microbiology/Virology Antifungal antifungal Inhibitor drug-resistant Fungal CgGal11A CgPdr1 infection C. glabrata inhibit iKIX-1 iKIX 1 inhibitor